• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    LifeQ Unveils New 24-Hour Sleep Solution

    Babson Diagnostics Welcomes New Clinical Advisor, Andrew Carroll

    EvoEndo Names CEO and Chief Operating Officer

    Electromedical Products International Forms Scientific Advisory Board

    Sonendo Bolsters its Operational Executive Team
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Checking Up on Surgical Robotics

    Building a Network: How Synchron Is Developing a New Device—and a New Market

    Six Lessons Learned on Developing a Strong Company Culture

    As Hiring Slows, Companies Look Inward to Fulfill Talent Needs

    Artificial Intelligence: Medtech Opportunity or Health Danger?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Halkey-Roberts Corporation

    Providence Enterprise USA Inc.

    LEMO USA Inc.

    Cirtec Medical

    NDH Medical Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    6 Considerations for Companies on the Cusp of Being Acquired

    3 Key Elements to Consider When Managing a Medtech Sales Force

    Tech-Enabled Virtual Speech Therapy Improves Speech & Communication Skills

    Practical Strategies for Digitization and Integration in Medtech Manufacturing

    Sensors: The Heart of Minimally Invasive Equipment Technology
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Halkey-Roberts Corporation

    Providence Enterprise USA Inc.

    LEMO USA Inc.

    Cirtec Medical

    NDH Medical Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Study Shows Real-World Significance of EyeArt AI Eye Screening System From Eyenuk

    Data validates the prowess of the EyeArt AI System for diabetic retinopathy screening.

    Business Wire10.02.19
    Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, announced that a published study1 of more than 100,000 consecutive diabetic patient visits analyzed using the EyeArt AI Eye Screening System. The largest study of AI in health care reported that the EyeArt AI System achieved greater than 91 percent in both sensitivity and specificity for detection of referable diabetic retinopathy (DR). The study found the EyeArt AI System to be a safe and effective, fully automated tool to advance the worldwide need for diabetic retinopathy screening.
     
    “The Value of Automated Diabetic Retinopathy Screening With the EyeArt System: A Study of More Than 100,000 Consecutive Encounters from People with Diabetes” was conducted in collaboration with the Doheny Eye Institute, one of the world’s leading ophthalmology programs affiliated with UCLA, and EyePACS, one of the largest global telemedicine programs for diabetic retinopathy screening.
     
    “Diabetic retinopathy is the most common cause of blindness in working adults, yet this blindness is largely preventable with regular screening,” said Dr. SriniVas Sadda, president and chief scientific officer of the Doheny Eye Institute. “As the number of people with diabetes increases worldwide, manual screening methods simply cannot scale. We’re excited about the EyeArt AI Eye Screening System’s effectiveness in real-world clinical practice and its ability to increase the volume of screenings while improving accuracy and consistency, and reducing costs.”
     
    The EyeArt AI Eye Screening System is the most extensively validated AI technology for autonomous detection of DR to date, tested in real-world settings on more than a half-million patient visits globally with more than 2 million images collected. This retrospective study of over 100,000 patient visits from real-world settings is complemented by another recent announcement of results from a prospective pivotal clinical trial that also demonstrated similar exceptional EyeArt AI System performance.
     
    “While everyone talks about the future promise of AI in health care, this study proves that AI’s ability to transform health care is already here and it is here to stay,” said Kaushal Solanki, Ph.D., founder and CEO of Eyenuk. “By conducting this study on a large cohort of patients from over 400 primary care clinics, it is gratifying to know that the EyeArt AI System consistently provides high diagnostic sensitivity and specificity, in real-world conditions that include variations in patient demographics, dilation status, camera types, image quality, photographer experience, patient workflow and clinic size. By giving clinicians who manage diabetes access to such robust AI eye screening at point-of-care, we can help them identify DR sooner and ensure that patients with vision-threatening disease receive timely treatment.”
     
    The peer-reviewed study assessed the diagnostic efficacy of the EyeArt AI System by analyzing 850,908 fundus images from 107,001 consecutive patient visits collected from 404 primary care clinics. The EyeArt AI System screening achieved 91.3 percent sensitivity and 91.1 percent specificity, showing that the EyeArt AI System performs well regardless of dilation status. Among 101,710 patient cases with the reference standard, only 910 (0.9 percent) were flagged as non-screenable by the EyeArt AI System. The study data represents a diverse range of patient demographics (age, race, ethnicity, sex) and includes images of varying quality captured by different photographers using a wide variety of cameras.
     
    DR is a complication of diabetes caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina). It is a silently progressing disease that at first may cause no symptoms or only mild vision problems. Eventually, it can cause blindness. The condition can develop in anyone who has type 1 or type 2 diabetes.2 It is estimated that one-third of all patients with diabetes will develop DR,3 making it the leading cause of vision loss in working-age adults.4
     
    While DR screening is recommended for all diabetic patients, less than half get screened annually even in the developed world. Since diabetic patients outnumber ophthalmologists by 1,600 to one in the United States,6 there are not enough eye care specialists to meet the DR screening needs of the growing diabetic population. Even for those receiving their annual screening, ophthalmology appointment wait times for DR screening can be weeks or even months.
     
    The EyeArt AI Eye Screening System provides fully automated DR screening in a single office visit, including retinal imaging, DR grading on international standards and reporting. The EyeArt AI System allows diabetes care providers to identify patients with referable DR in clinic, in real time, without needing eye care expertise on-site, so at-risk patients can be immediately referred to an ophthalmologist for further evaluation and treatment. This removes the biggest obstacles to annual DR screening and diagnosis: screening access and patient compliance. Once the patient’s fundus images have been captured and submitted to the EyeArt AI System, the DR screening results are available to view and export to a PDF report in less than 60 seconds.
     
    The EyeArt AI System was developed with funding from the U.S. National Institutes of Health (NIH) and is validated by the U.K. National Health Service (NHS). The EyeArt AI System has CE marking as a class 2a medical device in the European Union and a Health Canada license. In the United States, the EyeArt AI System is limited by federal law to investigational use. It is designed to be General Data Protection Regulation (GDPR) and Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.

    Learn more about the EyeArt AI Eye Screening System for Diabetic Retinopathy by watching this video.
     
    Eyenuk Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers for risk assessment and disease surveillance. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease. EyeArt is a registered trademark of Eyenuk Inc.
     
    References
    1 Bhaskaranand, Malavika, Chaithanya Ramachandra, Sandeep Bhat, Jorge Cuadros, Muneeswar Gupta Nittala, Srinivas Sadda, and Kaushal Solanki. “The Value of Automated Diabetic Retinopathy Screening With the EyeArt System: A Study of More Than 100,000 Consecutive Encounters from People with Diabetes.” Diabetes Technology & Therapeutics, July 23, 2019. https://doi.org/10.1089/dia.2019.0164.
    2 https://www.mayoclinic.org/diseases-conditions/diabetic-retinopathy/symptoms-causes/syc-20371611
    3 Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556-64. doi: 10.2337/dc11-1909.
    4 Prokofyeva E, Zrenner E. Epidemiology of major eye diseases leading to blindness in Europe: a literature review. Ophthalmic Res. 2012;47:171-188. doi: 10.1159/000329603.
    5 Fitch, K et al. Longitudinal commercial claims–based cost analysis of diabetic retinopathy screening patterns. Am Health Drug Benefits. 2015 Sep;8(6):300-8.
    6 http://www.icoph.org/ophthalmologists-worldwide.html and https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf
    Related Searches
    • dr
    • ai
    • europe
    • point-of-care
    Suggested For You
    FDA OKs GE Healthcare FDA OKs GE Healthcare's AI-Powered Chest X-ray
    MedX Health Signs Distribution Agreement for Canada, the United States, and Israel MedX Health Signs Distribution Agreement for Canada, the United States, and Israel
    AI Tool Identifies Cancer Outcomes Using Radiology Reports AI Tool Identifies Cancer Outcomes Using Radiology Reports
    Medtronic Partners with Viz.ai to Accelerate Adoption of AI in Stroke Centers Medtronic Partners with Viz.ai to Accelerate Adoption of AI in Stroke Centers
    Medica 2019—Sports Medicine Conference Preview Medica 2019—Sports Medicine Conference Preview
    Sequana Medical Announces Unconditional FDA IDE Approval to Start alfapump Pivotal Study Sequana Medical Announces Unconditional FDA IDE Approval to Start alfapump Pivotal Study
    PATH Develops Ethical Guidelines on the Use of AI in Healthcare PATH Develops Ethical Guidelines on the Use of AI in Healthcare
    Integra & Tissue Analytics Partner to Advance Wound Care Trial Data Analytics Integra & Tissue Analytics Partner to Advance Wound Care Trial Data Analytics
    Third FDA Clearance for Zebra-Med Third FDA Clearance for Zebra-Med's AI Solution for Brain Bleeds Alerts
    FDA OKs MRI-Safe Cochlear Implant with Android Connectivity FDA OKs MRI-Safe Cochlear Implant with Android Connectivity
    A Breakthrough for the Nightmarish Effects of PTSD A Breakthrough for the Nightmarish Effects of PTSD
    Eyenuk Combines AI Disease Detection and Human Grading to Launch Diabetic Retinopathy Diagnostic Eyenuk Combines AI Disease Detection and Human Grading to Launch Diabetic Retinopathy Diagnostic
    FDA OKs World FDA OKs World's First AI Solution for Flagging Pulmonary Embolism
    World World's First AI Chest X-Ray Triage Product Wins FDA Nod
    Using AI to Predict Breast Cancer and Personalize Care Using AI to Predict Breast Cancer and Personalize Care

    Related Breaking News

    • Diagnostics | Software & IT
      FDA OKs GE Healthcare

      FDA OKs GE Healthcare's AI-Powered Chest X-ray

      Helps radiologists prioritize critical cases with a suspected pneumothorax—a type of collapsed lung.
      GE Healthcare 09.12.19

    • MedX Health Signs Distribution Agreement for Canada, the United States, and Israel

      MedX Health Signs Distribution Agreement for Canada, the United States, and Israel

      MedX has previously signed an exclusive distribution agreement for Brazil with CBD Vida LTDA, a partner of Group Vida.
      Business Wire 08.09.19

    • Diagnostics | Digital Health | Software & IT
      AI Tool Identifies Cancer Outcomes Using Radiology Reports

      AI Tool Identifies Cancer Outcomes Using Radiology Reports

      Dana-Farber's AI tool performed comparably to trained human "curators" in detecting the presence of cancer.
      Dana-Farber Cancer Institute 07.26.19


    • Cardiovascular | Software & IT
      Medtronic Partners with Viz.ai to Accelerate Adoption of AI in Stroke Centers

      Medtronic Partners with Viz.ai to Accelerate Adoption of AI in Stroke Centers

      Technology can save time and increase access to stroke treatments.
      Medtronic 07.22.19

    • Diagnostics | Digital Health
      Medica 2019—Sports Medicine Conference Preview

      Medica 2019—Sports Medicine Conference Preview

      Professional athletes and sports doctors grant insight into their winning formulas at the 7th Medica Medicine + Sports Conference.
      Dr. Lutz Retzlaff, Medical Journalist 07.22.19

    Loading, Please Wait..

    Trending
    • Healthcare Changes Prompt Medtronic To Merge Sales Force Medtronic, Inc. Is Combining Its U.S. Ca
    • Philips Names New Supervisory Board Chairman
    • A New Approach To Post-Market Surveillance
    • FDA Clears Sanara MedTech's Advanced Surgical Solution
    • Titan Medical Licenses Most IP To Intuitive; CEO Steps Down
    Breaking News
    • CardioRenal’s TENOR Device Receives Breakthrough Device Designation from FDA
    • LifeQ Unveils New 24-Hour Sleep Solution
    • Babson Diagnostics Welcomes New Clinical Advisor, Andrew Carroll
    • EvoEndo Names CEO and Chief Operating Officer
    • Electromedical Products International Forms Scientific Advisory Board
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • Computer Concepts for Medical Device Design
    • IVD Manufacturers Are Being Put to the Test
    • The New State of Medtech Outsourcing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Stefan Pasiakos, PhD, Selected to Lead NIH Office of Dietary Supplements
    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing
    BGG Receives Patent for Saw Palmetto ID Method
    Coatings World

    Latest Breaking News From Coatings World

    Teal and Mackrill Director Geoff Mackrill Honored by BCF
    Evonik's TEGO Airex 923 Wins 2023 Ringier Technology Innovation Award
    120 Years HOFFMANN MINERAL - Success Through Innovation and Responsibility
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    LifeQ Unveils New 24-Hour Sleep Solution
    Babson Diagnostics Welcomes New Clinical Advisor, Andrew Carroll
    EvoEndo Names CEO and Chief Operating Officer
    Contract Pharma

    Latest Breaking News From Contract Pharma

    WuXi Increases Manufacturing Capacity in Germany
    Dragonfly Therapeutics Expands Clinical Leadership Team
    Innovent Enters into Clinical Trial Collaboration with Merck KGaA
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    L'Oréal North Asia President Discusses China's Consumer Sector Recovery & Premium Beauty Trends
    Kiehl’s Celebrates Pride by Supporting The Trevor Project
    L’Oréal & UNESCO Announce 2023 Laureates of the For Women in Science International Awards
    Happi

    Latest Breaking News From Happi

    Beauty & Wellness Brand Veracity Hires Chief Hormone Officer
    Skincare Brand Three Ships Beauty Expands Retail Partnership With Whole Foods
    Uoma Beauty Founder and CEO Sharon Chuter Steps Down
    Ink World

    Latest Breaking News From Ink World

    WestRock Advances its Commitment to a Sustainable Future
    Roland DGA Announces Key Service Department Personnel Changes
    The 2023 CPIPC Golf Outing is Teeing Off on June 21
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Appvion announces new, sustainable coatings for label facestocks
    Epson teams with 5 Gyres Institute to battle plastic pollution
    Maxcess opens new facility in India
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Harper Hygienics Launches Hemp-Based Intimate Care Wipes
    What You’re Reading on Nonwovens-Industry.com
    Biodiapers Signs Agreement with Sicam
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Augmedics Debuts New Features, Indications for xvision Platform
    Artelon Closes $20M Series B Funding
    Orthofix Unveils Seven-Year Outcome Data for M6-C Artificial Cervical Disc
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    DIC Acquires Photoresist Polymers Manufacturer PCAS Canada
    Arkema Collaborates with Habitat for Humanity Philadelphia
    Vitesco Technologies, onsemi Sign SiC Long-Term Supply Agreement

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login